M.Sc

CACTUS is a pioneering global scientific communications company. In everything we do, we want to accelerate the development of global scientific research, by helping science break through the confines of geography and language. To this end, we partner with academic and pharmaceutical communities worldwide and leverage the expertise of 1400+ professionals to create compelling, high-quality scientific communications. Browse through the tabs below for a closer look at CACTUS.

Post : Managing Editor

GeBBS Healthcare Solutions is a leading national provider of revenue cycle management (RCM) and health information management (HIM) solutions. Our in-depth healthcare industry expertise enables us to provide end-to-end solutions to successfully resolve our clients’ billing challenges, while embracing their overall business operations. GeBBS delivers a world-class infrastructure of highly skilled professionals, robust processes, and proprietary workflow engines. This makes us an ideal partner for our clients. When you need a medical coding company, we are the best choice.

Post : Trainee Medical Coding

Applications are invited from suitable eligible candidates for the post of Junior Research Fellow (JRF) to work at Institute of Pharmacy, Nirma University for full-time research on the project entitled “Formulation Development and Evaluation of Nanoparticulate systems for targeted delivery of anticancer agents”, funded by Nirma University, Ahmedabad, Gujarat, India.

Post: Junior Research Fellow

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds.  Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a

With a coastline of about 3,500 miles, inland sources in Rajasthan and Little Rann of Kutch, and the rock salt mines in Mandi, India have possibilities of attaining a high position in salt production among the salt producing countries of the world. As is known, apart from being an indispensable item of food, salt is an important raw material for the manufacture of several heavy chemicals e.g. soda ash, caustic soda and chlorine.

Established in 1889, the Indian Veterinary Research Institute (IVRI) is one of the premier research institutions dedicated to livestock research and development of the region. The institute with faculty strength of more than 275 has a major mandate of research, teaching, consultancy and technology transfer activities. The institute with its long scientific heritage has always enjoyed a certain prestige, a tradition all of its own.

Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world. We provide high- quality. affordable medicine trusted by healthcare professionals and patients in over 150 countries. It is also India's largest, most trusted and most valuable pharmaceutical company by market capitalization

Indian Council of Forestry Research and Education (ICFRE), an apex body in the national forestry research system, has been undertaking the holistic development of forestry research through need based planning, promoting, conducting and coordinating research, education and extension covering all aspects of forestry. The Council deals with the solution based forestry research in tune with the emerging issues in the sector, including global concerns such as climate change, conservation of biological diversity, combating desertification and sustainable management and development of resources. Topical research by the Council enhances public confidence in the ability of forest managers and researchers to successfully handle challenges related to natural resource management.

The flagship company of the Piramal Group, Piramal Enterprises Ltd. (PEL), has business interests in Pharma, Information Management, and Financial Services verticals of the group.  Towards the late 80s, we shifted our focus from textile to pharmaceuticals. We chose to invest significantly in the domestic formulation development business, while other companies in the industry concentrated on international generics. Our efforts proved successful with a track record of approximately 23% revenue CAGR. In 2010, our strategy accomplished a sale of its domestic formulations business at an unprecedented value of ~9x sales and ~30x EBITDA.